Addressing Disparities and Variations in Care in GU Oncology
AUAUniversity21 Joulu 2022

Addressing Disparities and Variations in Care in GU Oncology

Addressing Disparities and Variations in Care in GU Oncology CME Available: auau.auanet.org/node/37337 Host: Jay D. Raman, MD, FACS Guests: Kelvin Moses, MD, PhD and Svetlana Avulova, MD LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Discuss the impact of race and cultural barriers on optimal GU cancer care. 2. Evaluate financial toxicity as a barrier to optimal patient care in urologic cancer. 3. Incorporate culturally sensitive communications to ensure quality care and reduce biases across diverse patient populations. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Astellas AstraZeneca Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Lantheus Medical Imaging Merck & Co., Inc. Pfizer, Inc. Sanofi Genzyme

Jaksot(422)

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

Incorporating New IO Therapies - How to Properly Administer IO Therapies in an Infusion Suite

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

29 Loka 201837min

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer

Immuno-Oncology: A Focus on Bladder Cancer is the second in the 4-part series. Topics will include "non muscle invasive disease" and "muscle invasive disease" as well as "clinical trial evidence" and ...

24 Loka 201854min

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

AUA2018 Residents Forum: Public Policy and Advocacy in Urology: A Primer for Residents

Speakers: Christopher M. Gonzalez, MD, MBA James M. Dupree, MD, MPH

22 Loka 201817min

Incorporating New IO Therapies - Managing Patient Side Effects

Incorporating New IO Therapies - Managing Patient Side Effects

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

19 Loka 201830min

Immuno - Oncoloy: A New Class Of Drugs

Immuno - Oncoloy: A New Class Of Drugs

Immuno-Oncology: A New Class of Drugs is the first in the 4-part series. Topics will include "Tumor Immunotherapy", "Immunotherapy Drug Availability and Mechanisms of Action", "Vaccines", "Monoclonal ...

10 Loka 201842min

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer

Androgen Axis Agents and Bone Target Therapies in Advanced Prostate Cancer: What's New is the third podcast in a 4-part series. Topics will include "Manipulating the Androgen Axis: Androgen Biosynthe...

8 Loka 201856min

Incorporating New IO Therapies - Biomarkers

Incorporating New IO Therapies - Biomarkers

To improve clinicians’ understanding of current immunotherapeutic agents for the treatment of genitourinary (GU) cancer and to increase their ability to improve patient outcomes and the management of ...

4 Loka 201829min

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment

To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation are producing a serie...

28 Syys 201851min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
rss-narsisti
voi-hyvin-meditaatiot-2
aamukahvilla
rss-niinku-asia-on
rss-liian-kuuma-peruna
adhd-podi
psykologia
kesken
rss-vapaudu-voimaasi
rss-valo-minussa-2
dear-ladies
rss-koira-haudattuna
jari-sarasvuo-podcast
esa-saarinen-filosofia-ja-systeemiajattelu
leveli
rss-duodecim-lehti
rss-luonnollinen-synnytys-podcast
rss-ihana-elamani